MAP Pharmaceuticals, Inc.

Recent News
- February 7, 2013
  
  Allergan, Inc. and MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Period Under Hart-Scott-Rodino Act
- January 22, 2013
  
  Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
- January 2, 2013
  
  MAP Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference
Read More

Careers

Do you like to work in a fast paced, team-oriented environment with people committed to helping patients with neurological diseases? Explore our Careers section, meet our people and get to know us. We currently have opportunities for creative, experienced and talented individuals who want to join the MAP team.

Read More

LEVADEX^®
LEVADEX® (dihydroergotamine, USP) inhalation aerosol is an orally inhaled investigational drug for the acute treatment of migraine in adults.

Read More